With tailor-made nanocarriers, we will set new standards for the targeted, efficient and low-risk use of active pharmaceutical ingredients and other highly potent substances for medical and life science applications.
OUR VISION
We save human lives
by targeted use of highly potent substances
We rethink therapy
via tailor-made nanocarriers for efficiency and safety
We treat the untreatable
e.g. septic liver failure
NEWS
10th November 2025
BMFTR RESEARCH CAMPUS INITIATIVE: JOINT PROJECT APPROVED
As part of the initiative ‘Research Campus – Public-Private Partnership for Innovation’, the InfectoGnostics Research Campus Jena e.V. will receive funding from the Federal Ministry of Research, Technology and Space (BMFTR) for another four years starting in October 2025. SmartDyeLivery is a partner in one of seven lead projects in which automated organ-on-chip platforms will be used to test the effectiveness of substances against bacterial pathogens. ...
TECHNOLOGY CONFERENCE ‘ELMUG4FUTURE’: PRESENTATION OF OUR SMART PLATFORM
The conference, organised by the Industry Cluster Elektronische Mess- und Gerätetechnik Thüringen (ELMUG) eG on 21–22 October in Jena, provided a forum for exchange on innovative measurement technology in the life sciences sector. SmartDyeLivery also presented its platform technology ...
SEVENTHALLIANCE COMMITTEE OF THE ATHANA CONSORTIUM
On 16 October 2025, the seventh committee of the ATHANA alliance met, this time at the University Hospital Jena. During the two-hour meeting, all eight project partners presented their progress. The focus was particularly on the newly developed test samples and their application.
